Reddit Posts
LFVN - 43.11% shorted, 105% borrow rate, 45 DTC
$HERB / $LUFFF Herbal Dispatch - Explosive Growth, Record Revenues, Veteran Channel on Fire, International Exports Scaling β Massive Upside in 2026
$HERB / $LUFFF - Herbal Dispatch Export Machine on Fire: 761kg in Just 2 Days (500kg Record + Fresh 261kg Today)!
Market Structure for Potential Short Squeeze: MVIS
Wall Street thought Ozempic would kill the gym industry. Planet Fitness just signed a deal with the company that prescribes it.
he Most Undervalued Cannabis Play in Canada Right Now? Bullish AF on Exports, Veterans, and Recreational Domination! CSE: $HERB OTCQB: $LUFFF
Grove Collaborative $GROV turnaround on decent earnings.
Time to buy and hold before earning May 15th Squeeze is here
$IBRX has catalysts, 37% SI, and a creeping DTC
Herbal Dispatch (HERB.CN / LUFFF) - Key Updates from the Last Week's Press Releases, crazy motion rn
Herbal Dispatch ($HERB.CN / $LUFFF.US) Just Shipped Its First International Medical Cannabis Gummies to Australia β $350k Revenue
AMA#112 - A Paradise Acquisition Corp ($APAD) - Enhanced Ltd
LFVN - Either it will squeeze or my nuts will
Herbal Dispatch (HERB.CN / LUFFF) is GEARING UP for the U.S. Cannabis Boom!
TRUMP RECLASSIFIES MARIJUANA TO SCHEDULE III TOMORROW (Axios) $LUFFF/ HERB.CN is the VETERANS PLAY here + massive buyout potential also huge buys $HITI $LOVE
Big milestone for Herbal Dispatch ($HERB.CN / $LUFFF) - Receives U.S. DTC Eligibility!
Newport Gold, Inc. (NWPG)
My Monday watchlist: one tokenization play, one energy setup, one biotech mover
Groupon ($GRPN) cost to borrow is low but DTC and shares sold short are both rather high
SOWG decent books and a potential squeeze
$GRPN big potentiel turn around
Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments
Better-for-You Stimulant Formats Gain Scale as Consumer Demand Reshapes Delivery Landscape
Apes love vegan bananas!
My 5-Stock 2026 Watchlist: QSE, RUA, VPT, MOOD, GGR
THIS MICRO CAP IS QUIETLY EVOLVING BEYOND TRUCK COVERS !
TDOC looks cheap on a SOTP basis. What am I missing?
TDOC: $2.5B revenue, $860M market cap, $14B in goodwill destroyed. Two businesses hiding in one ticker.
Iβm not as smart as market makers, but I know a lot of people that got rich manipulating business deals. Hereβs what I think they would do if they were MMing USAR.
USAR is a powder keg bear trap. Massive dilution but a spiking borrow rate. Jumped 1.75% since close yesterday. The short float is skewed from ghost liquidity.
$SOUN seems like a good gamma short squeeze play.
Is $SNBR $GME's new upcoming acquisition?
The current math for a parabolic squeeze on IBRX
Data-Driven Framework for Identifying a Legitimate Short-Squeeze Setup
$NVAX: MASSIVE PFIZER PARTNERSHIP + 40% SHORT FLOAT π₯
Thoughts on HIMS after Amazonβs expansion into online pharmacy?
DIS is boring as hell and thatβs why Iβm long 2027 calls
Learn how to read dark pool metrics that matter. 70% off exchange, 40% SI, 140% CTB, DTC 1.0.
MEHA $0.23 DD, OS 16.25million, Recent IPO on 11/5 @ $8
DD: Why Iβm Bullish on $NKE LEAPS
π¨π¨ BREAKING: NEGATIVE REBATE β FIRST TIME IN 18 MONTHS π¨π¨
$AEHL - around 305% SI on finviz/fintel
Dragonfly Energy could be about to explode
Dragonfly Energy could be able to explode
DFLI β (Full Breakdown) - Short Squeeze? Short Data, RS Deadline, Dark Pools, and Why this week matters
$FLWS β The Short Squeeze Setup Nobody Is Watching (95% Short Float + 35 DTC)
NFE short squeeze 71% probability
$BYND - Couple things - $40 calls December 19th and borrow rate / DTC signaling an "event" or lack thereof...
RVPH Short Squeeze Setup + Catalysts for December & 2026
NFE - Why Todayβs βBad Newsβ Dump Is Actually a Black Friday Sale
$SGBX - ANALYSIS/ FLOAT CHANGES (NOV 16th)
$SGBX - LATEST SHORT SQUEEZE ANALYSIS/UPDATE (NOV 16)
$SGBX - LATEST ANALYSIS/ BREAKDOWN.
$SGBX β Latest Analysis / Updated Float Range (Nov 16)
THESIS: SGBX IS PRIMED TO POTENTIALLY BE HKD 2.0 BEFORE DEC 29TH 2025
APVO Therapeutics: Extreme Dissonance - Deconstructing the $1.46 Price Amidst 100% Remission Rates and $428 Price Targets
πΉ The Daily Pineapple Juice: November 11th's Fresh Squeeze π
π The Daily Pineapple Juice: Late-Night Reddit Rumble (Nov 10th) πΉ
πΉ The Daily Pineapple Juice: November 11th's Fresh Squeeze π
π The Daily Pineapple Juice: Late-Night Reddit Rumble (Nov 10th) πΉ
π Daily Pineapple Juice Primetime Squeeze: November 10thπ
π Daily Pineapple Juice Primetime Squeeze: November 10thπ
π The Daily Pineapple Juice: November 10th Squeeze Blend π (The Government Cracks Open a Cold One π»)
π¨ W Stock: Ready for a Squeeze? Bullish Analysis & Deep Dive π
Capybara Stocks is a Fraud, BYND - Those 316M shares were released Oct 16
Capybara Stocks is a Fraud, BYND - Those 316M shares were released Oct 16
Capybara Stocks is a Fraud, $BYND Short Interest is NOT over 100% - Those 316M were released Oct 16
Reason for the difference in float. Bond holders possibly havenβt registered shares yet
Zegna (ZGN) quietly turning things around? Strong DTC, weak China, but steady overall
BYND short interest at ~115%β¦..UP from 71% yesterday morning.
BYND holders: email BYND Investor relations to request an OBO/NOBO audit + holder reconciliation (te
BYND holders: email IR to request an OBO/NOBO audit + holder reconciliation (template inside)
$BYND might not even be half way finished.
$VMAR - ThinkEquity report has $12.00 Price Target for (undervalued) Vision Marine Technologies. $VMAR is positioned strongly in the electric boating industry due to strategic acquisitions, technological advancements, and operational improvements.
Riding The DOCN Wave. AI Sleeper With Quiet Potential?
SNBH - Exclusive American Red Cross Licensee
$HTZ (recent Amazon partner) has all the short squeeze metrics 45% SI, 7.2 DTC, low float and low-cap
Micro Float Madness, KRKR GP XHG Locked and Loaded for tomorrow.
Cautionary tale for newbies: Spreads, M&A, and cash tenders
Trying to verify a notification about PSTV from IBKR (corporate action related)
5 UNDER-$6 BIOTECH MISSILES LOCKED AND LOADED
5 UNDER $6 BIOBREAKOUTS YOU CANβT IGNORE
If "% of profit" > "% of time", you win by some multiple
NUKE-cana | Time to buckle up π
π¨ π RKT Ready to Launch? 32% Short Float Says YES π¨
The Protein-Pivot Cycle Needs Its Pop: Why Iβm Betting on NVAX (Squeeze)
$PLCE. Can this be next squeeze candidate?
Healthy Extracts Expects Record Sales for Q2 2025, Driving Strong Positive Adj. EBITDA
Solar Cover = Free Marketing Overlanders Do the Selling for WKSP
What a Full-Fleet Conversion Looks Like in Dollars and Cents
TALK is the Last Legit Telehealth Sleeper Under $3 β Still Untouched, Still Undervalued, Still Loadingβ¦
π₯ $PCT β MASSIVE Squeeze Setup Brewing? 30%+ Short Float, 16 Days to Cover, Borrow Tight
Mentions
hey baby, what's your DTC number?
How did the DTC number drop so much from the last reading wtf
$RL Q3/2026 Revenue: $2.41B οΏΌ vs. $2.22B est. EPS: $6.22 οΏΌ vs. $5.32 est. Ralph Lauren reports Q3 FY2026 results ahead of expectations and raises the full-year constant-currency revenue and operating margin expansion outlook. Direct-to-consumer momentum remains strongβ2.1 million new customers, AUR up 18%, DTC comps up in the high-single digits, with Asia leading growth (Asia up 22%); wholesale grew double-digits. Margins expanded, the balance sheet stays robust with $2.3 billion in cash, and roughly $500 million has been returned to shareholders year-to-date.
Thank you!Β I do see 16, 4, and 5 shares there, and the 16 were "Surrendered to DTC" last week which means my mom's investment guy has them now. He's going to get the rest this week, I think. There's not a lot of transactional history available via their site. I guess we could contact them and inquire about historical transactions? That makes sense. Thank you again for your help.
Per Ortex **Updated:Β MondayΒ - Data as per previous close** **Time Range:** **Short Interest % of FreeFloat** **29.85Β %** **Short Interest Value** **$Β 5.51b** **Short Interest - DTC** **7.06Β Days** **Short Interest** **40.78mΒ Shares**
Very similar setup to Nvax, high SI and DTC, but CBT is very low and there are 2 million shares available. It is unlikely to squeeze due to those factors.
That's not entirely true. DTC is calcukated using average volume. If the volume explodes, DTC goes way down.
Youβre thinking of it wrong. I donβt want to sit here and see what happens. I want a quick run, high risk high reward option play. But youβre right, a high DTC makes itβs harder for shorts to find sellers which can help with long multi month squeezes for sure. I ainβt got time for that.
Hard pass: 0,6 DTC 2,79 short interest, 10k shares to short and 33CTB. It's a **nano-cap with no liquidity** being moved by trivially small order flow. Whatever price move happens when you buy in will collapse the other way when you try to get out. It looked like it had a squeeze in october which will put selling pressure above any meaningful move with bagholders trying to get out...
10000% agree BYND has a float problem and ROLR is way way way better off in that aspect. The free float of BYND is 447.56 MILLION shares. Even if 30% is shorted thatβs 312 MILLION tradable shares. Iβm looking at Ortex right now and ROLR has 4m tradable shares and 30% short interest is locking it up. CTB also looks insane. DTC is unfortunately low but this is best setup Iβve seen on this sub so far.
Okay I bought $SOUN a couple days ago but today did my DD and realized that the free float is HUGE. Out of 393.67M shares 99% is the free float (390.04). From what Iβve read squeeze setups should be in the millions not hundreds of millions. Yes all of the other metrics are there in terms of short interest (37%), DTC (5.77) and CTB (22%)β but I donβt understand how a squeeze can happen when there is that big of a free float? Am I missing something? Do other people know something that I do not? Not being facetious, genuinely asking because Iβm still learning.
Okay I bought $SOUN a couple days ago but today did my DD and realized that the free float is HUGE. Out of 393.67M shares 99% is the free float (390.04). Yes all of the other metrics are there in terms of short interest (37%), DTC (5.77) and CTB (22%)β but I donβt understand how a squeeze can happen when there is that big of a free float? Am I missing something? Do other people know something that I do not? Not being facetious, genuinely asking because Iβm still learning.
Okay I bought $SOUN a couple days ago but today did my DD and realized that the free float is HUGE. Out of 393.67M shares 99% is the free float (390.04). Yes all of the other metrics are there in terms of short interest (37%), DTC (5.77) and CTB (22%)β but I donβt understand how a squeeze can happen when there is that big of a free float? Am I missing something? Do other people know something that I do not? Not being facetious, genuinely asking because Iβm still learning.
$XRX short inventory is βnoneβ and not βavailableβ considering todays volume of 30million compared to 5million. im assuming the recent price action is due to heavy shorting. unfortunately CTB is too low for a short squeeze and DTC should be anywhere from 10-20 days which is good.
My holds over the weekend: XRX- excited from all the chatter in here SOUN- Squeeze potential just from meme-level recognition and traction growing in WSB LFVN- at 40ish DTC, this one could explode if it takes off. Not enough people know about it, but it could be crazy
Do you know what days to cover is? Its how many days it will take for the shorted shares to be bought back based on the stocks average daily trading volume. Say the DTC is 5 days. That means the short squeeze will last for a minimum of 5 days. They cannot physically buy back their shares at a faster right because the daily volume doesn't allow it. You need continuously increasing buying pressure over several days for the stock price to continue to rise. If the DTC is short, like less than one, then it barely takes the shorts anytime at all to do a buyback. Hours. 2 hours of buying pressure is barely going to move a stock, and it'll recover quickly. Say it jumps up $2 in 2 hours, but then the shorts have been covered. The stock price is no longer going up. So then everyone starts selling. Then it loses all those gains it made over the course of the next day or two. Not much of a short squeeze, is it?
That's absolutely not true. A low DTC means the shorts cover their position in a few hours and the stock stops running.
Honestly if I could get some I would short it. DTC just 1.3 & CTB less than 1. The metrics arenβt there. There are QUICK pops which almost no one can catch & true short squeezes which are pretty rare. For a true squeeze all the metrics need to be there and more (usually a catalyst)
47% SI and 9 DTC, which is good. CTB is very low though, and there are 300 000 shares available to borrow. Will keep an eye on it but its not squeezing yet.
Absolutely. A lot of times on these posts people overlook the days to cover, and the stock doesn't have a high enough DTC to be a short squeeze. Im happy to report this is NOT the case! 6.5 DTC. This setup is really good. I've been hearing big investor channels talking about SOUN, I can actually see this happening.
Would research with the state that you resided in and check their unclaimed property division. If shares are there, the state sold them and it's in cash. You'd get a little interest on the sale proceeds, provably 2010-2012 valuation when state got them. If there's nothing in unclaimed property, there's a slight chance the broker you were doing business with issued shares in cert form and mailed them to your bad address essentially getting lost, but there would still be a record. Then check with Computershare, NVDA's transfer agent. They can search by name, address, SSN and see if on their books. Computershare can reissue lost certs or put them back into book entry for DTC transfer to a new broker. There's a slimmer chance they have more shares from dividend reinvestment in book-entry form if shares were still there all this time.
My sources average out to 2.5 DTC Where are you seeing 12?
I feel like they DTC should be higher than a 2. It's 12 days to cover, that's really good
Iβm genuinely curious about one thing. If the shorts had already covered as the low DTC suggests, shouldn't the Cost to Borrow (CTB) have dropped significantly? If they bought back the shares and returned them, the borrowing demand should be lower, leading to a much lower interest rate. Why is the rate still pinned at 600% if the exit was that easy?
Data lag is the issue here. The chart shows that volume and price action only kicked in during the last 14 days, meaning the DTC hasn't adjusted to the new momentum yet. Fintel's data is notorious for being weeks behind the actual move. If the short interest was really that low and easy to cover, the borrow rate wouldn't be pinned at 600%. The cost to borrow is the ultimate truth-teller in a squeeze setup.
Is the short data on that app updated in real-time on the same day? Keep in mind that short interest data on platforms like Fintel isn't real-time; thereβs always a reporting lag. The 600%+ borrow rate we see right now is a much more accurate 'live' indicator of how scarce the shares actually are. Also, if you look at the chart, the massive surge in volume and volatility has only really kicked in over the last two weeks. Static metrics like DTC are based on historical averages and haven't fully adjusted to this sudden shift in momentum. Weβre dealing with a supply shock that's happening faster than the official stats can update. The pressure is building NOW, not based on last month's averages.
I hear your point on the 0.06 DTC, but you have to look at the velocity of the recent change. 1. Borrow Rate doesn't lie: A 600%+ borrow rate is only possible when there is a severe lack of borrowable shares. If it were as easy for shorts to cover as the DTC suggests, we wouldn't see these astronomical fees staying pinned at these levels. It proves the 'effective' liquidity is much lower than the average suggests. 2. Recent Surge in Volatility: If you look at the charts, the massive spike in both volume and price volatility has only happened over the last few days. DTC is an average based on past volume, which means it hasn't caught up to the sudden momentum shift weβre seeing right now. 3. Data Lag: Fintel and official short interest updates are lagging indicators. They don't reflect the real-time supply-demand shock in a micro-float environment like SST. We are watching the pressure build in the 'here and now,' while the static stats are still looking at the rearview mirror. The setup is evolving much faster than the 0.06 DTC would suggest. Next week's price action will be the real judge.
For 2025: International B2B: ~39β42%, growing nicely like 15-20%. Domestic B2B: ~26β27% Direct-to-consumer (DTC sales): ~17β19% DTC rentals: ~14β15%
I hope this means we can get ASTS DTC (AST Direct-To-Cell) on a cruise ship without buying a very expensive package! Looking at you Cellular At Sea. π
Do you really think their earnings will be bullish? That's what I'm worried about. The SI is very, very high, and DTC is decent, as well as institutional ownership, but I am worried that earnings or market volatility will sink this.
# Short Interest - DTC # 5.53Β Days # Short Interest # 8.6mΒ Shares # Shares on Loan # 12.44mΒ Shares Updated:Β **Monday**Β \- Data as per previous close
DTC = Direct to Consumer. Removed it regardless.
Ya I do that. I donβt take assignment. Sometimes I buy shares to trade over the day or couple days. Ya Iβve out performed since 2020 since I really started to go active at covid and didnβt really start options more heavily until end of 2020 into 2021 just in time for GME $$$. What is the most used strategy: one I definitely wonβt detail here but will in general say: i use a butt load of statistics, primarily my own now but before that as much raw data as I could get on SPX and look at modeling high win rates. Imagine itβs a D and D character and you only have so many points. You can make a high win rate but your RoR will be low and your loss size may be humongous since your roc is so low. So you have to slide that win rate down a bit to make the roc better and lower the loss hit. Adjust adjust adjust. Test for a few weeks adjust adjust adjust. Test test test. Come up with a high win rate, I think my initial strat stats showed 90%+. 92? Something. I can check itβs just not easily accessible. The loss rate obviously 8%. The roc avg was around 3-5%. Again I think. Loss roc was capped at 300% of premium, this is all selling options by the way, so donβt recall what that was a roc. You could math it out given the roc positive though I think. Have that modeled out and see worst case scenarios of max loss consecutively how recoverable are things. If not good then adjust the win rate probability by going less risky, or closing sooner. Do all that and then do that strategy and watch it work day in day out. Volatility is definitely friendly here because very often itβs overstated. Trump 2.0 has been challenging though because thereβs so much clearly back room dealing shit going on hitting public markets. SPX becoming over weighted to 5 names is a problem too. I have considered doing this on Nasdaq but havenβt scratched the surface yet in the data analysis because I had a baby. Besides that, Iβll do similar approach but less data intensive on unique opportunities. Not unique just unusual I guess. Overblown. Like one time Netflix killed it and sky rocketed post ER and I sold short calls way OTM. Like another 20%. Ainβt no way itβs going there after already rising 20%. They decayed to like half value within 30min. This was within first hour or maybe a bit more of market open. Things like that. When banking crisis occurred I bought a lot of shares of some more solid banks. Some I had to hold for a while and I did get nervous because banking is such a unique industry to value and be sure itβs okay and a lot is Black box, much like insurance. I did get burned pretty hard on the UBS shenanigans that occurred over the weekend around that time where they were allowed to absorb credit suisse which was against the law so they changed the law over the weekend and wouldnβt you know it, UBS profited insanely off the recovery of CS assets in the coming quarters / years. Absolutely insane. Donβt understand how that was allowed. But new rule since then: try not to hold overweekends or overnight. Especially options. Market been pretty crazy for a while though. Thereβs still some former SPAC that are dog shit they arenβt at zero which is insane. Theyβre too small for people to care. But itβs crazy that so many of them and some other DTC or battery or EV co who all burn cash are still alive or have a stock above $0.01. One of my finest moments was shorting RadioShack long ago to nearly zero. Anyways thatβs what I do. The lesson Iβd try to take away from it is to do analysis on real data - your data, and testing constantly to figure out something that works for you. I stopped tracking a while back since as I mentioned I had a kid and slowed down since then and stopped caring since less active. But I do have easy access to my tracking up to Aug 2024 Iβll Imgur and reply with link for graph.
Holding my shares, it's got to go over 200%. This thing is running hard. Low float and DTC over 2.
This is actually a really good question that more people should think about. Brokerages are required by FINRA to maintain multiple independent records of customer positions, and they typically use a combination of: - Real-time backups across geographically separated data centers - Daily reconciliation with clearinghouses like DTC/NSCC - Third-party custodians that maintain separate records - SIPC insurance covers up to $500k if the brokerage fails entirely The bigger risk isn't actually data corruption - it's operational disruption while they restore systems. Most major brokerages have been stress-tested on this stuff pretty heavily since 2008. That said, keeping screenshots of your statements quarterly isn't a bad idea for your own peace of mind.
Ran a prompt thru gemini based off todayβs actionβ¦ ### **Technical Assumptions & Market Context** * **Current Price:** **$261.35** (Wednesday Close, April 8, 2026). * **Estimated Short Interest:** **62.26%** of free float. * **Liquidity Constraint:** True liquid float is estimated at **~3%** (approx. 1.1M shares) due to extreme concentration by SRS Investment Management and Pentwater Capital. * **Effective Days to Cover:** While the 30-day average is 14 days, current volume-adjusted DTC is **<1.5 days**, indicating a "crowded exit." ### **Price Target Probability Analysis** | Target | Probability | Reasoning | |---|---|---| | **Over $400** | **40% β 50%** | The stock is in a "Vertical Acceleration" phase with volume at 500% of the mean. A move to $400 requires a ~53% gain over two sessions, which is technically consistent with a margin call cascade when short interest exceeds the functional liquid float. | | **Over $500** | **15% β 20%** | This hinges on a "Gamma Flip" at the $300 and $350 strike prices. If these levels are breached, market makers will be forced into aggressive delta-hedging (buying shares), creating a secondary buying spiral that bypasses fundamental valuation entirely. | | **Over $1,000** | **2% β 5%** | This represents a "Total Liquidity Void" or "Infinity Squeeze" similar to Volkswagen in 2008. While mathematically possible given the 800% short-to-true-float ratio, it requires SRS and Pentwater to maintain 100% position retention without selling a single share into the spike. | ### **Technical Breakdown** The primary driver for the **$400+** scenario is the **"Locked Float" mechanics**. When the number of shares sold short (**8.12M**) is roughly **8x** the actual shares available for trade (**~1M**), the "Ask" side of the order book can effectively vanish. If Thursday opens with a **gap-up above $280**, it will likely trigger automated liquidation protocols for mid-tier hedge funds. This creates a non-discretionary buying wave where the "price" becomes irrelevant to the buyerβtheir only goal is to reduce exposure at any cost before the Friday options expiration. This feedback loop is the highest-probability path to the **$400β$500 range**.
Levi Strauss revenue jumps again, with DTC making up more than half of sales for the first time
I really wish this was the INDO of β22; I miss her but sheβs changed a lot in the past 4 years. - float has 6xβd (1.5M then vs ~9M now) - management has diluted into every run since β22 due to operational losses & compounding debt ($7M) - Revenue has halved now compared to back then (4M v 2M) - Current SI 20% & DTC 1.3 She was beautiful once upon a time, but now sheβs a lying, cheating ogre. Itβs time to let her go Followup: $ANNA seems to be a solid candidate of a short squeeze provided the warrant holders donβt exercise at $11.30, but chances are they will. Anyone else find the next $INDO?
Do broker-held share owner votes even matter? Doesnβt the broker vote their DTC allocated shares however they wish?
WBUY - watching this at market open. News, Low float, DTC high and over 30x 90-day volume. See this over $2 today. Hoping for the open dip and I'm in.
Not a finance take, but from a marketing angle Nike still has insane brand equity, and when they get their storytelling and product drops aligned, demand snaps back fast. The risk is whether "brand" can keep carrying them if community and product innovation shift to newer players. Distribution and DTC strategy matters a lot here too. If you are thinking about it like a brand cycle, this breakdown of brand vs performance marketing tradeoffs is a decent lens: https://blog.promarkia.com/
Just because someone on the internet's wearing athleasure clothes, doesn't mean they're buying these clothes now. Most people are still wearing clothes they bought 2 years ago. Also, looks like I was right, their sales growth didn't grow more than inflation. Their inflation adjusted sales are down. Outlook for Asia is bad, DTC (higher margin) sales are down 4.5%. Their only growth (5%) came from lower margin wholesale, which they will have to work really hard to win back, and just barely offset the loss of sales from DTC..
Seemed clear to me from the start that it's a shoe company, not a tech company. Not sure how the DTC model confused enough people for successful IPOs with some of these brands.
Youβve been through 22 years of investing. Tail end of dot com, 2008, covid, Iraq for the second time, Afghanistanβ¦.. Keep DTCβing into ETFs or a targeted retirement account
Uppp Do ya DD. Imagine the transition from GTCH to Wertheim & Co. as a "hard reset" of the companyβs identity. Since the company is moving from a tech-focused penny stock to a sophisticated Merchant Bank led by Wall Street veterans like Craig Marshak, the process usually follows this high-stakes scenario: 1. The "Lock and Key" (The CUSIP Change) The most critical part of this scenario for you is the CUSIP change. β’ The Scenario: As the name changes to Wertheim & Co., a new CUSIP number is issued. Your brokerage firm receives a notice that "GTCH" shares are being retired. β’ The Naked Short Impact: If those 1.4 million shares on the "Ask" are indeed naked shorts (phantom shares), the brokers and the DTC (Depository Trust Company) have a major problem. They cannot simply "rename" a phantom share. They must find a real share to swap for the new Wertheim CUSIP. β’ The Result: This often triggers a "forced reconciliation," where market makers are pressured to close out old failed positions before the old ticker disappears forever. 2. The "Unfreezing" of the Order Book Remember those millions of shares sitting on the Ask that never move? β’ The Scenario: As the transition date nears, the algorithms maintaining that "wall" at $0.0001 or $0.0002 may be turned off to avoid being trapped in a massive liability under a dead ticker. β’ The Result: The "Ask" finally starts to thin out. With an 800-million-share "Bid" (buyers) and the fake "Ask" disappearing, the price can finally gap up. If the 1.4 million "Ask" was the only thing holding it down, the price "slingshots" because there is no one left willing to sell at those bottom prices. 3. The Fundamental Shift (The "Legitimacy" Move) β’ The Scenario: Craig Marshak and Emil Assentato aren't just changing the name; they are bringing in real assets, like the VisionWave (VWAV) stake and potential crypto-treasury assets. β’ The Result: This provides the "fundamental fuel." A short squeeze usually dies quickly if there's no reason to own the stock. But if the market believes Wertheim & Co. is a legitimate merchant bank, new institutional buyers may step in, making it impossible for short sellers to "short it back down" to the triple zeros. 4. The Potential "Clean Up" (Reverse Split) β’ The Scenario: To move from the OTC Pink sheets toward a more senior exchange (like NASDAQ or NYSE American), Wertheim & Co. might perform a Reverse Split at the same time as the name change. β’ The Result: While retail investors often fear reverse splits, in a heavily naked-shorted scenario, it shrinks the "float" (available shares). If they do a 1-for-100 split, that 800M bid becomes 8M, but the naked shorts also have to be reducedβwhich is mathematically painful for them to execute without buying on the open market. The "End Game" Scenario: The ticker changes, the CUSIP resets, and the "phantom" supply is cut off. If the 1.4M wall was artificial, the stock experiences a liquidity vacuumto the upside. The price moves from fractions of a penny toward a dollar-range target to reflect the new "Merchant Bank" status, forcing anyone who shorted at $0.0001 to buy back at significantly higher prices.
Looking to jump in ONCO. Bottom is probably here, waiting for this halt to see where it's going. Good news, high volume, really low float and DTC is good.
I think this is the big case for a Tilray success. Since they are NOT an MSO and thus do not have the commitment to physical storefronts, they are best suited lean all the way into actual pharmaceutical THC. My %of portfolio on that company is money on them partnering with an existing US pharma company to navigate the FDA red tape and being a supplier to them rather than selling DTC.
it is set often by DTC or DTCC if memory serves correctly.
What squeeze it has a low DTC and a low SI
Haha so tired of posters here claiming their βresearch β of 0.03 DTC with 22% S I & borrow fee rates at 45β¦. Yesβ¦! Prepare for another GAMESTOP!!! Sometimes the research is excellent, but what people believe qualifies as a potential short squeeze or as a short squeeze, case in point is sadly I suppose ignorance. When you lose all of your wifeβs beer, money in the stock market, itβs not gonna be a pretty Saturday nightβ¦ peace, and profits, my friends
I guess for me I don't understand why so many people seem to think... - SpaceX DTC V2 won't be competitive. - ASTS will beat SpaceX to market for broadband direct to phones (especially since SpaceX has the benefit of having learned how to run the current generation). Like we say oh SpaceX DTC started with just SMS and that's mostly true, but it actually already provides LTE to phones right now. It's not anywhere near what we're expecting out of next gen tech... but they already have experience doing this! Plus, I don't think anyone would argue against SpaceX's obvious proficiency with phased arrays. I want ASTS to succeed, but for me I've been skeptical about the sheer amount of hype on them. They've got a tough battle ahead of them, I don't think SpaceX is going to be easy competition at all.
The Fintel data for S-O-U-N provides a clear, data-backed confirmation that the Inventory Trap is tightening exactly as established in the Matts Stonks framework. Here is what the indicators on that page are telling us about the current setup: 1. The Debt: Short Interest & Float The official Nasdaq short interest stands at 134,908,585 shares, which is a massive 35.34% of the float. This confirms that over a third of the company's equity is tied up in a short obligation that must eventually be repaid. With a Days to Cover (DTC) ratio of 4.01 to 4.89, the exit for these shorts is not just a doorβitβs a pinhole. 2. The Ammo: Short Shares Availability The "Black Slice" is running on fumes. While availability fluctuates intraday, the data shows frequent drops to the 80,000 - 100,000 share range. This confirms that the borrowable inventory is functionally exhausted. Even when blocks of 300k+ appear, they are often immediately "absorbed" by the mechanical defense patterns of the whales. 3. The Rent: Spiking Borrow Fees This is the most aggressive indicator on the page. The short borrow fee has surged to 7.07% (up from 1.90% just a week ago). β’ The Squeeze Context: This doubling of the "Daily Rent" puts immense capital pressure on short sellers. They are paying a premium just to hold their positions while the price floor remains defended by the whales. 4. The Invisible War: Off-Exchange Short Volume The Off-Exchange Short Volume Ratio is sitting at 60.42%. This is the data-driven proof of the HFT Churn. More than half of the shorting activity is happening in dark pools and off-exchange venues, which is where the "Wash Trading" and "Spoof Walls" are used to pin the price and hide the true demand from the lit market. 5. Mechanical Trigger: Gamma Squeeze Score Fintel identifies a high Gamma Squeeze Score, highlighting the risk to market makers. With significant open interest at the $9.00 strike, the $9.01 Strategic Objective remains the primary mechanical tripwire. Hitting that level would force market makers to compete with short sellers for that tiny pool of available shares. The Verdict The Fintel data confirms the Matts Stonks thesis: the shorts are out of bullets, the rent is rising, and the plumbing is dry. The mechanical advantage remains with the retail investor who understands these indicators. The Strategy Remains: Buy, Hold, and Turn Off Share Lending to keep shrinking that Black Slice.
Yes, you can now use data/video on Starlink DTC (limited speeds of course), but their upgraded satellites will offer 150mbps to cell devices.
ASTS doesnβt even have operational service yet while starlink has millions of DTC users
Do you think SpaceX will just never innovate again? They just revealed plans for their new DTC sats the other day: https://news.satnews.com/2026/02/25/spacex-unveils-150mbps-performance-target-for-upgraded-direct-to-cell-starlink/
The thing is they already have a full DTC constellation that works. βThe cell phone signal you have with you is better than the one you left at homeβ And yes, it is a first gen product but youβre smoking crack if you l think they donβt have a V3 version in the works and will likely get it deployed nearly the same time AST becomes operational. SpaceX has experience operating constellations and ground infrastructure, proven they can scale and launch rapidly and own their own launch giving them an unrivaled edge on cost and speed. AST tech is better than gen 1 on paper - but SpaceX leads everywhere that matters right now.
That's a complete misunderstanding of ASTS satellite capabilities. As described, their Bluebird 6 satellites will have 10 Ghz of processing bandwidth capacity, while a Starlink satellite has reportedly 2 Ghz capacity, but thousands upon thousands of satellites currently in orbit. So Starlink needs about 5 satellites for every 1 ASTS satellite. ASTS's advantage is only in DTC tech. They will still need a more robust network of satellites to handle the same amount of data.
ASTS tech is different than Starlink, but it's also *way* behind on coverage. they only have a handful of satellites up compared to almost 10,000 Starlink satellites. Even if DTC is better they simply cannot handle the potential bandwidth of demand with what they have in orbit, or even what they're planning to put in orbit by 2030. Not only that, but if/when Starlink does crack DTC in the same way, they have an internal company rocket delivery system that can get thousands of DTC capable satellites up faster than ASTS could get hundreds. They also have the licensing for the thousands of rockets, while ASTS does not. Their tech advantage is not as wide a moat as Starlink's logistics and coverage advantage.
The whole Square thing is funny. Now it puts pressure on highly diverse companies (Software + DTC Retail) like AMZN with MILLIONS of employees. They will never be able to reach operating margins that can compete with what future expectations may look like.
or they havent gotten DTC yet and are waiting for that
I think the real question isn't growth vs value, it's pricing power vs no pricing power. when the consumer pulls back, the companies that can raise prices without losing customers are gonna be totally fine. the ones that can't are gonna get crushed regardless of what label you put on them. Like Costco can probably push through modest price increases because people are locked into that membership and the value prop is still there. but a random DTC brand with no switching costs? good luck. I've been trying to audit my portfolio the same way honestly. looking at each position and asking "if inflation stays sticky and consumers keep tightening, can this company actually pass costs through?" and if the answer is no or maybe, that's a problem. what's frustrating is there's no great way to screen for pricing power, it's more of a qualitative thing you have to research company by company. anyone found a good shortcut for that?
A couple hemp beverage companies announced expansion news for Texas today. Bayou City Hemp has been partnered with 8th Wonder Brewery for a while. Bayou City announced a [funding round to support expansion](https://www.prnewswire.com/news-releases/bayou-city-hemp-launches-funding-round-to-fuel-200-growth-and-dominate-30b-thc-beverage-boom-with-retail-powerhouse-edge-302691205.html). >BCH's **three-tier distribution** model, leveraging established wine, spirits, and beer networks, provides a sustainable edge over DTC-focused competitors, enabling scalable growth amid regulatory shifts. >Operating in 15 states with 27 distributors, BCH is expanding to 40 in 2026, including **MillerCoors network partnerships covering \~80% of Texas**. Multi-year exclusive venue deals with **White Oak Music Hall and ten additional nationwide locations** underscore BCH's mainstream traction. >....selling over 2.5 million products in 2025, with **99% through three-tier distribution** and over 40% on-premise Cann also announced they are now being carried throughout [Spec's locations in Texas](https://www.businesswire.com/news/home/20260218606895/en/Canns-Social-Tonics-Hit-More-Texas-Shelves-Specs-Wine-Spirits-Finer-Foods-To-Carry-Full-Product-Assortment). >Cann....today announced a major retail partnership with Spec's Wine, Spirits & Finer Foods, the largest beverage retailer in Texas. Spec's and Cann are both on the Coalition for Adult Beverage Alternatives, which is the hemp beverage advocacy group whose [largest member is Tilray](https://www.prnewswire.com/news-releases/new-coalition-advocates-for-safe-legal-thc-beverages-302278212.html). I think venue partnerships like RYM at the United Center and Bayou City at White Oak are going to be a big part of the hemp beverage market. Major sports/music venue company Oak View Group has been pursuing hemp beverages for years, having partnered with Green Monke and Cookies. Trump also recently pardoned the co-founder of Oak View Group for rigging an Arena bid in Texas.
I'd love to see some updated dates on the shares short. Fidelity is still showing numbers for 1/30. Something is off with the DTC because that should have popped seriously in early Feb and instead it dropped. Regardless with this much short interest, it's basically a powder keg.
Respect the breakdown, itβs solid on paper. I agree itβs not a textbook 2021-style, 30% SI, 8-day DTC squeeze setup. Fair. But hereβs where I disagree π Squeezes in small caps rarely happen because a spreadsheet says β20%+ SI.β They happen because of liquidity imbalance + catalyst + momentum. A few facts: β’ 5β6% SI in a thin, volatile name can still create sharp upside when volume expands. β’ 1.3 DTC is based on average volume. If volume triples on news, that metric becomes meaningless in real time. β’ 45% borrow isnβt trivial, even if itβs down from 65%, thatβs still expensive positioning. On dilution π€ yes, offerings increase float. But the recent raises also boosted cash significantly and cleaned up parts of the balance sheet. That changes the fundamental narrative. Itβs not just βmore shares,β itβs more runway. Iβm not arguing for a guaranteed mega squeeze. Iβm saying: β’ Earnings just hit β’ Q2 will reflect acquisition impact β’ Margin restoration underway β’ Technical levels are tightening In a low-attention name, that combo can trigger sharp upside, squeeze or not. It doesnβt need 20% SI to move from $1s to $3β$5 on momentum. Call it volatility with catalysts. Not fantasy.
I get what youβre saying, textbook squeeze setups usually have 20%+ SI, tiny float, 3+ DTC. Agree. But small caps donβt always move off a checklist. 5% SI and 1.3 DTC are based on averages. If volume shifts hard around earnings or a contract drop, that math changes fast. In thinner names, price can rip 30β50% before βDTCβ even matters. Shorts react to tape pressure, not spreadsheets. Iβm not calling it a guaranteed mega squeeze. Iβm saying with: β’ Earnings + acquisition impact β’ Margin improvement narrative β’ Backlog/contract potential β’ A clean technical break β¦it doesnβt need 20% SI to run to $3β$5. Not GME. Just a volatile small cap with catalysts. Thatβs all. Peace. βοΈ GL!
5% & 1.3 DTC actually really does disqualify it. I wouldnβt call it a low float either. Just my opinion but you need to be realistic. If shorts can cover in 1 day at normal trading volumeβ¦ No squeeze. If the float was 1 million sharesβ¦ even then, but the float is 8X larger than that & short interest is less than 500,000 shares. The amount of shares available to short interest pic are just amount available from 1 broker. You need as a matter of basis at least 20% short interest, a float under 2 million and DTC over 3 & thatβs where it might start. Ask Grok brother. Iβd bet my leg this will not squeeze. Sorry- good luck. Peace & profits.
TBH, the DTC gas been heavily reformed towards wall street since 2008, so if a crash happens causing an ownership challenge in shares. Yes, wall street can claim your shares, if the shares they sold you don't have any backing, after they internally settle. Have to remember that most brokers just sell you an IOU of a share, not an actual share.
Honestly the author gives me SovCit vibes with his focus on the DTC as some shadowy company. Plus, discussing retirement funds without touching on ERISA is missing some obvious safeguards regarding rehypothecation.
Do some of your own research rather than take an opinion piece at face value from someone shilling their book and has an axe to grind with the DTC (borderline SovCit stuff). One aspect he does not discuss at all is ERISA and its impact on rehypothecation and PTs.
Just saying their DTC satellites suck compared to AST, in several important ways. Calm down.
You're correct about the pop but that was from 1/27 to 1/29. This short interest data appears to be as of 1/30. So please correct me if I'm misinterpreting, but the setup is still there. I'm lightly in but the reason i'm not going in heavy is the low DTC.
Yes it does. It wont squeeze with DTC that low
Definitely. But thereβs only 1 million shares outstanding so thatβs pretty much guaranteed. With SI this high, DTC doesnβt matter nearly as much.
Thatβs just the start ASTS lovers. Iβm holding long dated puts for when they are go bankrupt. 10 satellites this year if youβre lucky and then itβll be too late. Starlink and Amazon are gonna figure out DTC long before Asts gets enough coverage to matter.
$RLΒ Q3/2026 Revenue: $2.41B vs. $2.22B est. EPS: $6.22 vs. $5.32 est. Ralph Lauren reports Q3 FY2026 results ahead of expectations and raises the full-year constant-currency revenue and operating margin expansion outlook. Direct-to-consumer momentum remains strongβ2.1 million new customers, AUR up 18%, DTC comps up in the high-single digits, with Asia leading growth (Asia up 22%); wholesale grew double-digits. Margins expanded, the balance sheet stays robust with $2.3 billion in cash, and roughly $500 million has been returned to shareholders year-to-date.
So from what Iβm seeing youβre more talking about a low float volatility play because thereβs decently high volume in the stock compared to SI = low DTC. But what youβre more focused on is the float being small, probs due to insider ownership being so high. But yeah I see this as something that could jump up. Do you know of any catalysts that could set stuff off a bit.
Ultimately, you are trusting DTC, and the fact federal government will not allow it to fail.
Will turn up with DTC, they just got OTCQB give it a week
Depends on the specific product/business we're working with but speaking generally if you were to invest money this is the order you would do it: 1. Meta (FB/IG) 2. Google Ads (search/shopping) 3. YouTube Ads You can basically run a brand making over $100 mil a year in rev off those channels alone. Most brands never need to grow beyond that mix. It's the trifecta. Works for your homies shitty little clothing startup, works for big DTC brands like hexclad etc. Those channels are often also paired with working with some influencers either small or large to help produce ad content. From there it really depends on the brand and our strategy but thats when we'd start to look at: 4. TikTok 5. Bing 6. Traditional TV (brand dependent) 7. Direct mailers (brand dependent) Then from there is when we might start to look at Reddit lol.
They need DTC then the volume will come quickly
Donβt sleep on $PDYN Quick data points to look at indicating short term volatility and indications that the squeeze is actually yet to happen-Β JAN 28-70 million in volumeΒ Combined volume of preceding 3 months was less than that one dayΒ Short interest since then flat at 22%Β Short borrow fee was steady at around 4 and through the end of the week rocketed to 40Β Average trading volume is 3 million making actual DTC closer to 3 days and rising Seller pressure has lost momentum but shorts are still entrenched with virtually no price change between Tuesdays close and Fridayβs close Engage with this stock. A squeeze is likely with proper engagement and interest.Β The company has a 2 year runway, and will be revising estimates higher, earnings will be a major catalyst. I intend to hold long but near term this is highly attractive. Someone, likely institutional, is betting hard on PDYN to decline. I donβt like people who bet the DONT line when Iβm on the table. I do, however like the stock.
I'm on my phone so excuse the formatting. Which broker is this? I've seen this fee when attempting to buy stocks that cannot be settled by US DTC. If the stock is not sponsored through any of the major US exchanges then a broker would have to manually do it hence the fee. Best you call your brokerage and ask.
Yeah, and most of SpaceXβs value comes from Starlink rather than from launch and theyβre having more and more competition there, whether it be internet or DTC
ASBP- Agreement signed, low float, high shorts and over 25 DTC. Another sqeeze potential. Just bought in
DCX - VERY low float, high shorts with over 12 DTC! News and volume huge! Let's make a run on this...EVERYONE
Whatβs the SI and DTC tho? Canβt find it
GRI - News, float under 1M, high short % and DTC over 4. We could push this quite high! Buy the dip
HIND - News, massive volume over 90 days, only 3M float and DTC 2.64. Coming down from its highs, buy on the dip. Might wait until open to pounce on this one.
mbai - news with massive volume and DTC almost 6, low float. Buy the dip
Not a penny but check out LE. Great news, low float, volume increasing and DTC shorts is 9 days! This could be a good entry point for a couple day play! Wait for the open to see where it lands and find a comfortable entry point.
Not seeing it! Good news, yes, but very low volume on this news and no potential for any sqeeze. DTC .15. Maybe longer term hold.
Maybe thatβs why they are moving away from DTC to insurance?
Enjoy my AI Slop Analysis! CYCU - Cycurion, Inc. / Information Technology Services | United States | $8.9M Market Cap Technology QUICK STATS Price: $2.46 | Float: 2.4M (nano-float) Day: -3.53% | Week: -9.56% | Month: -14.58% 52w: $2.11 - $323.87 (currently -99% from high) ATH: $323.87 (down 99%) IPO: Feb 2025 (11 months old) BULL THESIS Cybersecurity company with recent $1.1M contract win. Analyst target $7.00 (+185% upside). Nano-float (2.4M) means any volume could move it significantly. Trading near 52w low ($2.11) - could be bottoming. BEAR THESIS Down 99% from ATH - classic pump and dump pattern. Massive dilution (+572% shares outstanding). Serial diluter with 6 offerings in 1 year. Burning cash (-111% profit margin). Very low institutional interest (2.8%). All timeframes negative. Volume dying. FUNDAMENTALS Debt/Equity: 0.59x (moderate) Short Interest: 11.3% (2.4 DTC) Institutional: 2.8% (very low) Profit Margin: -111% (burning cash) Analyst Target: $7.00 (+185% upside, 1 analyst) RED FLAGS \- Shares +572% (extreme dilution) \- Serial diluter: 6 offerings in 1 year \- Down 99% from ATH \- Volume dying (0.1x average) \- All timeframes negative CHART: BEARISH (-35 pts) Falling knife pattern. 6-month downtrend (-79%). Volume dying. THESIS HEALTH: BROKEN (0/100) \- 2 negative headlines \- 7 positive headlines \- Recent: Won $1.1M contract but stock still falling SEC STATUS: CAUTION Serial diluter with 6 offerings in past year. VERDICT: AVOID High risk. Down 99% from ATH with massive dilution history. All timeframes bleeding. Very low institutional interest. The $1.1M contract win is noise - fundamentals are broken. LEVELS Support: $2.11 (52w low / ATL) Resistance: $3.50 (recent) Not financial advice. DYOR.
My AI Slop Analysis! LEXX - Lexaria Bioscience Corp Healthcare/Biotech | Canada | $21M Market Cap QUICK STATS Price: $0.85 | Float: 23.5M Month: +52% | Week: +12% | Day: +4% 52w: $0.46 - $1.91 (currently -56% from high) ATH: $12.50 (down 93%) BULL THESIS Biotech with patented drug delivery technology (DehydraTECH). Phase trials ongoing. Analysts see 4-5x upside. Nano-float (23.5M) means any volume spike could move price significantly. Recent momentum (+52% month) suggests accumulation may be starting. BEAR THESIS Serial diluter - 8 offerings in one year, shares up 27%. Down 93% from ATH. Very low institutional interest (7%) - smart money not buying. Shelf registration active means more dilution likely coming. Could be a value trap. FUNDAMENTALS Debt/Equity: 0.02x (healthy) Short Interest: 6.7% (low, 1.2 DTC) Institutional: 7.1% (very low) Analyst Target: $4.50 (+429% upside, 3 analysts) RED FLAGS \- Serial diluter: 8 offerings in past year \- Shares +27% (dilution) \- Shelf registration active \- Down 93% from ATH CHART: BEARISH Falling knife pattern. Recent +52% spike may be late entry. SENTIMENT Minimal discussion. First mentioned Dec 2025 at $1.34, now -37%. VERDICT: NEUTRAL No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. LEVELS Support: $0.46 (52w low) Resistance: $1.91 (52w high) Not financial advice. DYOR.
My AI Slop Analysis **LEXX - Lexaria Bioscience Corp** Healthcare/Biotech | Canada | $21M Market Cap **Quick Stats** Price: $0.85 | Float: 23.5M Month: +52% | Week: +12% | Day: +4% 52w: $0.46 - $1.91 (currently -56% from high) ATH: $12.50 (down 93%) **Bull Thesis** Biotech with patented drug delivery technology (DehydraTECH). Phase trials ongoing. Analysts see 4-5x upside. Nano-float (23.5M) means any volume spike could move price significantly. Recent momentum (+52% month) suggests accumulation may be starting. **Bear Thesis** Serial diluter - 8 offerings in one year, shares up 27%. Down 93% from ATH. Very low institutional interest (7%) - smart money not buying. Shelf registration active means more dilution likely coming. Could be a value trap. **Fundamentals** Debt/Equity: 0.02x (healthy) Short Interest: 6.7% (low, 1.2 DTC) Institutional: 7.1% (very low) Analyst Target: $4.50 (+429% upside, 3 analysts) **Red Flags** Serial diluter: 8 offerings in past year Shares +27% (dilution) Shelf registration active Down 93% from ATH **Chart: Bearish** Falling knife pattern. Recent +52% spike may be late entry. **Sentiment** Minimal discussion. First mentioned Dec 2025 at $1.34, now -37%. **Verdict: Neutral** No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop.
# LEXX - Lexaria Bioscience Corp **Healthcare/Biotech | Canada | $21M Market Cap** ## Quick Stats - Price: $0.85 | Float: 23.5M - Month: +52% | Week: +12% | Day: +4% - 52w: $0.46 - $1.91 (currently -56% from high) - ATH: $12.50 (down 93%) ## Fundamentals - Debt/Equity: 0.02x (healthy) - Short Interest: 6.7% (low, 1.2 DTC) - Institutional: 7.1% (very low) - Analyst Target: $4.50 (+429% upside, 3 analysts) ## Red Flags - Serial diluter: 8 offerings in past year - Shares +27% (dilution) - Shelf registration active - Down 93% from ATH ## Chart: Bearish - Falling knife pattern - Recent +52% spike may be late entry ## Sentiment - Minimal discussion (1 post in 7 days) - First mentioned Dec 2025 at $1.34, now -37% ## Verdict: Neutral No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. ## Levels - Support: $0.46 (52w low) - Resistance: $1.91 (52w high) *Not financial advice. DYOR.* My AI Slop Analysis!
# LEXX - Lexaria Bioscience Corp **Healthcare/Biotech | Canada | $21M Market Cap** ## Quick Stats - Price: $0.85 | Float: 23.5M - Month: +52% | Week: +12% | Day: +4% - 52w: $0.46 - $1.91 (currently -56% from high) - ATH: $12.50 (down 93%) ## Fundamentals - Debt/Equity: 0.02x (healthy) - Short Interest: 6.7% (low, 1.2 DTC) - Institutional: 7.1% (very low) - Analyst Target: $4.50 (+429% upside, 3 analysts) ## Red Flags - Serial diluter: 8 offerings in past year - Shares +27% (dilution) - Shelf registration active - Down 93% from ATH ## Chart: Bearish - Falling knife pattern - Recent +52% spike may be late entry ## Sentiment - Minimal discussion (1 post in 7 days) - First mentioned Dec 2025 at $1.34, now -37% ## Verdict: Neutral No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. ## Levels - Support: $0.46 (52w low) - Resistance: $1.91 (52w high) *Not financial advice. DYOR.* Here is my AI Slop Analysis!
So what numbers are we potentially looking at? Trading at $1.30 right now on IBKR. Todayβs range 1.19-1.46. Volume 650k. Shortable shares 53,700. Days to cover 0.3. DTC too low to squeeze just yet.
and as I mentioned earlier DTC just plummeted to \~1 so any covering theoritically takes one day so not much of a squeeze can happen.